国药在阿联酋的三期结果公布了，86%保护率。
musketeer
2020-12-09 15:34
观网怎么没看到新闻。这个结果还是不错。86%保护率，99%的抗体检测阳性，100%阻止进展到普通和重症。
MOHAP, in collaboration with Department of Health Abu Dhabi, DOH, has reviewed Sinopharm CNBG’s interim analysis of the phase III trials, which shows Beijing Institute of Biological Product’s inactivated vaccine to have 86 percent efficacy against COVID-19 infection. The analysis also shows the vaccine to have 99 percent seroconversion rate of neutralising antibody and 100 percent effectiveness in preventing moderate and severe cases of the disease. Furthermore, the analysis shows no serious safety concerns.
